RecruitingNot applicableNCT06168292

Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Center, Korea
Principal Investigator
Sang Myung Woo, M.D
National Cancer Center
Intervention
ID-RFA and Radiotherapy(procedure)
Enrollment
53 enrolled
Eligibility
20 years · All sexes
Timeline
2024 – 2030

Study locations (1)

Collaborators

Boston Scientific Corporation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06168292 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials